Literature DB >> 16000553

Radioimmunotherapy for colorectal cancer.

Monica M Bertagnolli.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16000553     DOI： 10.1158/1078-0432.CCR-05-0485

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  3 in total

1.  Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer.

Authors:  Marc Ychou; David Azria; Cathy Menkarios; Patrick Faurous; François Quenet; Bernard Saint-Aubert; Philippe Rouanet; Monique Pèlegrin; Caroline Bascoul-Mollevi; Dominique Guerreau; Jean-Claude Saccavini; Jean-Pierre Mach; Jean-Claude Artus; André Pèlegrin
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

2.  In Vitro Characterization of 177Lu-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer.

Authors:  Tabassom Mohajershojai; Preeti Jha; Anna Boström; Fredrik Y Frejd; Paul J Yazaki; Marika Nestor
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 5.738

3.  Generation of small 32P-labeled peptides as a potential approach to colorectal cancer therapy.

Authors:  John M Abraham; Yulan Cheng; James P Hamilton; Bogdan Paun; Zhe Jin; Rachana Agarwal; Takatsugu Kan; Stefan David; Alexandru Olaru; Jian Yang; Tetsuo Ito; Florin M Selaru; Yuriko Mori; Stephen J Meltzer
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.